Zeotech Executes Nonbinding Agreement with i3 Consulting on Development, Trials of AusPozz Metakaolin Products
MT Newswires Live
Jan 14
Zeotech (ASX:ZEO) executed a nonbinding memorandum of understanding with i3 Consulting to collaborate on the development, trials, and potential adoption of Zeotech's AusPozz high-reactivity metakaolin in concrete applications, according to a Wednesday Australian bourse filing.
The agreement commenced on Tuesday and will expire 18 months from the date.
i3 Consulting will identify suitable projects, tenders, and opportunities to support the trials of AuzPozz metakaolin products in concrete applications.
The firms completed an initial trial of AusPozz in wind farm applications using a 50% AusPozz mix design.
Its shares rose over 1% in recent trading on Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.